PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Life Sciences, Manipal Academy of Higher Education, Dubai, United Arab Emirates.\', \'Department of Mechanical and Industrial Engineering, College of Engineering, Qatar University, Doha, 2713, Qatar; Biomedical Research Center, Qatar University, Doha, 2713, Qatar. Electronic address: ahasan@qu.edu.qa.\', \'Department of Molecular Genetics, Faculty of Biological Science, North Tehran Branch, Islamic Azad University, Tehran, Iran.\', \'Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, PO Box 346, Ajman, United Arab Emirates.\', \'Department of Electrical Engineering, Qatar University, Doha, 2713, Qatar.\', \'Department of Nanotechnology, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.\', \'Department of Microbiology, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Electronic address: haghighat.s@iaups.ac.ir.\', \'Department of Nanotechnology, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Electronic address: mojtaba.alahati@alumni.ut.ac.ir.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0753-3322(20)30752-610.1016/j.biopha.2020.110559
?:hasPublicationType
?:journal
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
is ?:pmid of
?:pmid
?:pmid
  • 32768882
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all